The main limitation is the inclusion of PD patients without screening for common PD-causative genes and sporadic PD causative factors (e.g., SNCA, GBA, MAPT and LRRK2 genes), which might mask the effect of ADORA2A rs5760423 and CYP1A2 rs762551. Here, LRRK2 is linked to Parkinson disease.